Related Experiment Video

Updated: Aug 12, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

[Chlamydial pathogenesis: diagnostic and therapeutic consequences]

B de Barbeyrac1, C Bébéar

  • 1Laboratoire de bactériologie, centre national de référence des infections à Chlamydia, université Victor-Segalen, Bordeaux-II, 146, rue Léo-Saignat, 33076 Bordeaux cedex, France. bertille.de.barbeyrac@u-bordeaux2.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|May 17, 2005
PubMed

Insights

Chlamydiae bacteria can persist after antibiotic treatment, potentially causing chronic inflammation and disease. Detecting these persistent forms is challenging, impacting treatment effectiveness and patient outcomes.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Context:

  • Chlamydiae are common human pathogens responsible for significant diseases.
  • Clinical persistence of Chlamydiae is a critical factor in pathogenesis.
  • Inflammation-driven pathology underlies severe sequelae like sterility (Chlamydia trachomatis) and coronary artery disease (Chlamydia pneumoniae).

Purpose:

  • To highlight the challenges in diagnosing chronic chlamydial infections.
  • To discuss the implications of persistent chlamydial antigens on ongoing inflammation.
  • To question the optimal therapeutic strategies for chlamydial infections given treatment failures.

Summary:

  • Chlamydiacidal antibiotics may eliminate viable bacteria but leave persistent antigens.
  • These non-cultivable forms can trigger prolonged inflammation, contributing to disease.
  • Nucleic acid amplification tests are crucial for diagnosing these atypical forms.

Impact:

  • Understanding chlamydial persistence is vital for managing inflammatory diseases.
  • Improved diagnostic methods are needed to detect chronic infections.
  • Re-evaluating treatment protocols may be necessary to address persistent chlamydial infections.

More Related Videos

Forward Genetic Approaches in Chlamydia trachomatis09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells07:42

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

Related Concept Videos

Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...